External Quality Assessment for Enterovirus 71 and Coxsackievirus A16 Detection by Reverse Transcription-PCR Using Armored RNA as a Virus Surrogate

Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Journal of clinical microbiology (Impact Factor: 4.23). 08/2011; 49(10):3591-5. DOI: 10.1128/JCM.00686-11
Source: PubMed

ABSTRACT Three armored RNAs (virus-like particles [VLPs]) containing target sequences from enterovirus 71 (EV71) and coxsackievirus A16 (CA16) and a pan-enterovirus (pan-EV) sequence were constructed and used in an external quality assessment (EQA) to determine the performance of laboratories in the detection of EV71 and CA16. The EQA panel, which consisted of 20 samples, including 14 positive samples with different concentrations of EV and either EV71 or CA16 armored RNAs, 2 samples with all 3 armored RNAs, and 4 negative-control samples (NaN(3)-preserved minimal essential medium [MEM] without VLPs), was distributed to 54 laboratories that perform molecular diagnosis of hand, foot, and mouth disease (HFMD) virus infections. A total of 41 data sets from 41 participants were returned; 5 (12.2%) were generated using conventional in-house reverse transcription-PCR (RT-PCR) assays, and 36 (87.8%) were generated using commercial real-time RT-PCR assays. Performance assessments of laboratories differed; 12 (29.3%) showed a need for improvement. Surprisingly, 4 laboratories were unable to detect EV71 RNA in any samples, even those containing the highest concentration of 10(7) IU/ml. Furthermore, the detection sensitivity for EV71 among all laboratories (82.1%) was substantially lower than that for EV (97.4%) or CA16 (95.1%). Overall, the results of the present study indicate that EQA should be performed periodically to help laboratories monitor their ability to detect HFMD viruses and to improve the comparability of results from different laboratories.

Download full-text


Available from: Shipeng Sun, Jul 28, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to find novel information concerning pathogen detection and some probable coinfection factors in hand, foot, and mouth disease (HFMD). In this study, 1104 clinically diagnosed HFMD patients were included. Enterovirus 71 (EV71), coxsackievirus A16 (CA16), and 14 different respiratory pathogens were examined from nasopharyngeal swabs using polymerase chain reaction (PCR) or reverse transcriptase PCR (RT-PCR). To evaluate the immune activation in HFMD patients, 8 cytokines and IgM antibodies to EV71 and CA16 from mild and severe patients were detected. Our results indicated that the severity of HFMD may affect the pathogen detection. The lower positive rates of enterovirus and respiratory viruses in severe HFMD cases by RT-PCR were probably related to stronger immune response. Therefore, immunological tests such as ELISA are essential supplements to PCR or RT-PCR in order to increase pathogen diagnosis in HFMD, especially in severe cases.
    Diagnostic microbiology and infectious disease 03/2013; 76(2). DOI:10.1016/j.diagmicrobio.2013.02.011 · 2.57 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: An external quality assessment (EQA) program for molecular detection of avian influenza A (H7N9) virus was implemented by National Center for Clinical Laboratory (NCCL) of China during June 2013. Virus-like particles (VLPs) that containing full length RNA sequences of hemagglutinin (HA), neuraminidase (NA), matrix protein (MP) and nucleoprotein (NP) genes from the H7N9 virus (armored RNAs) were constructed. The EQA panel comprising 6 samples with different concentrations of armored RNAs positive for H7N9 viruses and four H7N9-negative samples (including one sample positive only for MP gene of the H7N9 virus) was distributed to 79 laboratories in China that carry out molecular diagnosis of H7N9 viruses. The overall performances of data sets were classified according to the results of both H7 and N9. Consequently, 80 data sets were received (one participant provided two sets of results), which were generated using commercial (n = 60) or in-house (n = 17) real-time RT-PCR (qRT-PCR) kits and commercial assay employed isothermal amplification method (n =3). The results revealed that the majority (82.5%) of data sets correctly identified "H7N9 virus" while 17.5% of the data sets need to improve their diagnostic capability. The "improvable" data sets were derived mostly from false-negative results of N9 at relatively low concentrations. The false-negative rate was 5.6% and the false-positive rate was 0.6%. In addition, we observed varied diagnostic capabilities between different commercially available kits and in-house developed assays, with assay manufactured by BioPerfectus Technologies (Jiangsu, China) performing better than others did. Overall, the majority of laboratories have reliable diagnostic capacity.
    Journal of clinical microbiology 10/2013; 51(12). DOI:10.1128/JCM.02018-13 · 4.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Coxsackievirus 16 (CA16) is one of the major pathogens associated with Hand, Foot, and Mouth Disease (HFMD) in infants and young children. In recent years, CA16 and human enterovirus 71 (EV71) have often circulated alternatively or together in the Western Pacific region, which has become an important public health problem in this region. HFMD caused by CA16 infection is generally thought to be mild and self-limiting. However, recently several severe and fatal cases involving CA16 have been reported. Studies have shown that co-infection with CA16 and EV71 can cause serious complications in the central nervous system (CNS) and increase the chance of genetic recombination, which may be responsible for the large HFMD outbreak in Mainland China in 2008. For these reasons, recent studies have focused on the virological characteristics of CA16 and the development of CA16-related diagnostic reagents and vaccines.
    Human Vaccines & Immunotherapeutics 11/2013; 10(2). DOI:10.4161/hv.27087 · 3.64 Impact Factor